Pharmacologic study of paclitaxel administered with or without the cytoprotective agens amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors

J.L. van den Brande, V.R Nannan Panday, H. Rosing, J.H. Beijnen, J.B Vermorken

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)401-403
Number of pages3
JournalJournal of Clinical Oncology
Volume24
Publication statusPublished - 2001

Cite this